Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
clinical trials
drugs
life sciences
national blog main
onpattro
2
×
patisiran
acute hepatic porphyrias
akcea therapeutics
akin akinc
alnylam pharmaceuticals
aminolevulinic acid
anylam pharmaceuticals
boston
cardiomyopathy
fda
givosiran
inotersen
national top stories
neuropathy
new york
new york blog main
new york top stories
paul matteis
pfizer
rna interference
san diego blog main
san diego top stories
stifel financial
tafamidis
tegsedi
transthyretin amyloidosis
What
ago
2
×
alnylam
2
×
drug
fda
akcea
amyloidosis
approval
approved
attr
available
battle
debilitating
disease
genetic
indicated
interference
medicine
medicines
nod
oks
patients
pfizer
pharmaceuticals
quick
rare
rna
rnai
second
seek
sets
speedy
transthyretin
weeks
won’t
year
Language
Current search:
alnylam
×
ago
×
onpattro
×
@xconomy.com
5 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
Alnylam Won’t Seek Quick FDA Nod For Second RNAi Drug